MICHELLE DESHAZER: Open Payments
NPI 1295013795 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,987 in 152 payments from 17 companies in 2025. Trend: 2023 $3,179 · 2024 $1,968 · 2025 $2,987
Food & beverage: $2,519Education: $468
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $466 |
| ABBVIE INC. | 25 | $368 |
| GENZYME CORPORATION | 13 | $322 |
| PFIZER INC. | 13 | $300 |
| Novartis Pharmaceuticals Corporation | 16 | $205 |
| Regeneron Healthcare Solutions, Inc. | 8 | $198 |
| Lilly USA, LLC | 4 | $183 |
| UCB, Inc. | 12 | $179 |
| E.R. Squibb & Sons, L.L.C. | 7 | $174 |
| Galderma Laboratories, L.P. | 16 | $162 |
Products named: DUPIXENT, TREMFYA, CIBINQO, RINVOQ, Bimzelx, Sotyktu, SKYRIZI, EBGLYSS.
Industry payments across NC — which companies pay providers there.
